Mostrando 6 resultados de: 6
Filtros aplicados
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(4)
Bioquímica(1)
Fisiología humana(1)
Medicina forense; incidencia de enfermedades(1)
Origen
scopus(6)
Front-line medicines used in the treatment of tuberculosis
ArticleAbstract: Tuberculosis has emerged as an enormous global public health epidemic. Worldwide, it is the second lPalabras claves:Estreptomicin, Ethambutol, isoniazid, M. Tuberculosis, Pyrazinamide, rifampinAutores:Arráiz N., Bermúdez F.A., Leal E.M., Rodriguez M., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusIncrease of malondialdehido and nitric oxide in COPD patients
ArticleAbstract: Introduction: Chronic Obstructive Pulmonary Disease (COPD) is an entity characterized by the persistPalabras claves:Chronic obstructive pulmonary disease, Malondialdehyde, Nitric oxide, Oxidative profileAutores:Bello L.M., Linares S., Silva C., Valmore BermúdezFuentes:scopusInsulinoma associated with pituitary adenoma: A potential case of sporadic nem-1? A case study
ArticleAbstract: Insulinomas are neuroendocrine tumors derived from insulin-producing β cells located in pancreatic iPalabras claves:hyperinsulinemia, Hypoglycemia, Insulinoma, MEN-1, PROLACTINOMAAutores:Arias V., Awad A.A., Chávez C., David A., García C., Garicano C.M.D., Miquilena E., Molero F., Rojas-Quintero J., Silva C., Valmore Bermúdez, Velasco M., Vera M.Fuentes:scopusMolecular biology of glucose transporters: Classification, structure and distribution
ReviewAbstract: Hexoses like glucose, galactose and fructose serve as basic fuel molecules for eucaryotic cells. ThePalabras claves:Co-transporter, Facilitative diffusion, glucose, Glut, SGLT-1, SGLT-2, TransporterAutores:Acosta A., Amell A., Andara C., Añez J., Angulo V., Arráiz N., Bermúdez F.A., Carrillo M., Leal E.M., Linares S., Martins G., Mengual-Moreno E., Rodriguez M., Seyfi H.A., Silva C., Valdelamar L., Valmore BermúdezFuentes:scopusPharmacologic treatment of obesity: Present, past and future
ReviewAbstract: Obesity is a chronic, stigmatized and costly disease that is rarely curable and is increasing in prePalabras claves:body mass index, Energetic balance, Noradrenegic agents, obesity, Orlistat, Serotoninergic agents, SibutraminAutores:Amell A., Bermúdez F.A., Cabrera M., Leal E.M., Mengual-Moreno E., Rodriguez M., Silva C., Toledo A., Valdelamar L., Valmore BermúdezFuentes:scopusTumor necrosis factor as an inflammatory marker in patients with chronic obstructive pulmonary disease
ArticleAbstract: COPD is a chronic inflammatory disease that mainly affects bronchi less than 2 mm in diameter. ThisPalabras claves:Chronic obstructive pulmonary disease, Cigarette, inflammation, inflammatory mediators, Tumor necrosis factorAutores:Bello L.M., Silva C., Valmore BermúdezFuentes:scopus